Treatment of mycoplasma-contaminated continuous cell lines with mycoplasma removal agent (MRA).
Thirty-nine continuous adherent or suspension cell lines were treated with a quinolone antibiotic, Mycoplasma Removal Agent (MRA), for the elimination of chronic mycoplasma contamination. In preliminary experiments MRA did not show any cytostatic or cytotoxic effects on mycoplasma-free cell cultures in concentrations up to ten-fold the concentration used for mycoplasma eradication. Twenty-eight cell lines (72%) were effectively cleansed of the mycoplasma contaminants by MRA treatment. The persistent removal of the mycoplasma infection was monitored by three mycoplasma detection assays. In seven cell lines (18%) the mycoplasmas were resistant to treatment with MRA. The resistant species was mainly M. arginini followed by M. orale and A. laidlawii; however, other cell lines harboring these species were cured. Four cell lines (10%) which prior to treatment presented with decreased viability and poor or no cell growth were lost during or shortly after the exposure to the antibiotic. If an antibiotic elimination is attempted it is imperative to closely examine the effectiveness of treatment and possible eukaryotic cytotoxicity. The treated mycoplasma-free cells may also no longer express the original features as a result of treatment or the absence of mycoplasma.
Gignac
S M
SM
Uphoff
C C
CC
MacLeod
R A
RA
Steube
K
K
Voges
M
M
Drexler
H G
HG
D002470:Cell Survival / Q000187:drug effects; D004352:Drug Resistance, Microbial; D006801:Humans; D009174:Mycoplasma / Q000187:drug effects* / Q000254:growth & development; D015363:Quinolones / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000382:microbiology*
D015363:Quinolones; C074448:mycoplasma removal agent